You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 21, December 6, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Prognosis/ Outcomes
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Process Measures and Short-term Mortality for Acute Myocardial Infarction

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Bradley and colleagues1 evaluated the relationship between hospital compliance with process measures for acute myocardial infarction (AMI) and short-term cardiac mortality. The data demonstrate that compliance with Joint Commission on Accreditation of Healthcare Organizations and the Center for Medicare and Medicaid Services core process measures can account for about 6% of the variation in outcomes for this patient population. We believe that their suggestion for expanded process measure reporting as a way to improve quality of care is not supported by the available evidence.

Public reporting of performance measures may disenfranchise high-risk patients.2 Process measures may not be evidence-based and may reflect cost or political considerations. Examples include the selection of antibiotics for surgical infection prevention measures,3 the delayed adoption of a 48-hour stop time for prophylactic antibiotics following cardiac surgery despite data available from the Society of Thoracic Surgeons,4 and delayed acceptance of angiotensin-receptor blockers . . . [Full Text of this Article]

David McKalip, MD
dmckalip@neuro3.net
St Petersburg, Fla

Robert E. Harbaugh, MD
Department of Neurological Surgery
Penn State Milton S. Hershey Medical Center
Hershey, Pa



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Process Measures and Short-term Mortality for Acute Myocardial Infarction—Reply
Elizabeth H. Bradley and Harlan M. Krumholz
JAMA. 2006;296(21):2557-2558.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Hospital Quality for Acute Myocardial Infarction: Correlation Among Process Measures and Relationship With Short-term Mortality
Elizabeth H. Bradley, Jeph Herrin, Brian Elbel, Robert L. McNamara, David J. Magid, Brahmajee K. Nallamothu, Yongfei Wang, Sharon-Lise T. Normand, John A. Spertus, and Harlan M. Krumholz
JAMA. 2006;296(1):72-78.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.